In Brief: Lilly
Executive Summary
Lilly: Ronald Stowe joins as VP-government relations from Pacific Telesis. Lilly notes that in addition to state and federal government affairs, Stowe will be heading up international lobbying, an area in which Lilly says it is "expanding" its efforts. The move combines Lilly's D.C. state and federal government relations activities. Stowe will join Lilly's D.C office in early June to direct a staff that includes Federal Affairs Directors Ed Mihalski and Jay Bonnitt. Stowe's background in the telecommunications business creates a common bond with Lilly Chairman Randall Tobias who was previously with AT&T...
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth